Homeopathic Medicine (S #414) - 30c Liq 30 C Liquid is a Health Canada–registered human drug (DIN 02104962) held by Total Health Centre, containing Betaine Hydrochloride. Health Canada lists its status as Cancelled Post Market (status date 10 Sep 1996). Nexara Health has matched 26 registrations of Betaine Hydrochloride across 14 other regulated markets, 1 of them in the same strength and dosage form.
Health Canada registration
| DIN | 02104962 |
|---|---|
| Brand name | Homeopathic Medicine (S #414) - 30c Liq |
| Active ingredient | Betaine Hydrochloride |
| Strength | 30 C |
| Dosage form | Liquid |
| Route | Sublingual |
| Company | Total Health Centre |
| Status | Cancelled Post Market — 10 Sep 1996 |
| Class | Human |
| ATC | |
| AHFS | 92:02.00* ; See footnote |
| Regulator record | Health Canada DPD entry · Product monograph |
Betaine Hydrochloride registered in other markets
26 registrations of the same molecule in 14 national registries outside Canada. Each row is taken from the regulator's own published list; status is shown as the registry reports it.
| Country | Product | Marketing authorisation holder | Strength | Form | Status | Registry |
|---|---|---|---|---|---|---|
| United States | Dr.Jucre Rebirth Activating Toner | Naturecell Co., Ltd. | Liquid | listed | FDA NDC | |
| Australia | Cystadane | Rj | Oral powder 180 g | GE | PBS | |
| Bahrain | Cystadane | Recordati Rare Diseases, France. | 1 G | Oral Powder | POM | NHRA |
| Czech Republic | Amversio | — | 1G | Por Plv | R | SUKL DLP |
| Czech Republic | Cystadane | — | 1G | Por Plv | R | SUKL DLP |
| European Union (EMA) | Amversio | Serb SA | Authorised | EMA centrally authorised | ||
| European Union (EMA) | Cystadane | Recordati Rare Diseases | Authorised | EMA centrally authorised | ||
| Greece | Kloref Ef.tab (1035+675)mg/Tab Βτχ30(Σε Πλαστ.φιαλ) | Adelco A.e. Χρωμ. Αθην. Αφοι Ε. Κολοκοτρωνη | reimbursed | MoH deltio timwn | ||
| Ireland | Amversio 1 g oral powder | Serb S.a. | Oral powder | Unknown | HPRA | |
| Ireland | Cystadane 1g oral powder | Recordati Rare Diseases | Oral powder | Unknown | HPRA | |
| Luxembourg | CYSTADANE PDRE ORALE 1 g 1*1 FL. 180 G + 1*3 CUILLERES MESURE | — | RR | CNS liste positive | ||
| Netherlands | Amversio 1g, poeder voor oraal gebruik | Serb S.a. | Poeder voor oraal gebruik | Uitsluitend recept | EU national register | |
| Netherlands | Cystadane 1 g/g, poeder voor oraal gebruik | Orphan Europe SARL | Poeder voor oraal gebruik | Uitsluitend recept | EU national register | |
| Poland | Amversio | Serb S.a. | 1 g | Proszek doustny | URPL RPL | |
| Saudi Arabia | Cystadane | — | 1 | Inactive | SFDA | |
| Taiwan | Betaine Citrate "Profarmaco" | Profarmaco S.r.l. | （粉） | 已註銷 | TFDA | |
| Taiwan | Betaine Monohydrate | Parke Davis Division Of Warner-Lambert Co., | （粉） | 已註銷 | TFDA | |
| Taiwan | Betaine Monohydrate | Parke Davis Division Of Warner-Lambert Co., | （粉） | 已註銷 | TFDA | |
| United Arab Emirates | Cystadane® 1g | Recordati Rare Diseases, France, Puteaux | 1g/g | Powder | Active | EDE |
| United Kingdom | Betaine 2.5g/5ml oral solution | — | 0001 | NHS dm+d VMP | ||
| United Kingdom | Betaine 500mg tablets | — | 0001 | NHS dm+d VMP | ||
| United States | Betaine | Cosette Pharmaceuticals, Inc. | Powder, For Solution | listed | FDA NDC | |
| United States | Betaine anhydrous | AMINO GmbH | Powder | FDA NDC | ||
| United States | Betaine Anhydrous | Nuray Chemicals Private Limited | Powder | FDA NDC | ||
| United States | Betaine Anhydrous | Eton Pharmaceuticals, Inc. | Powder, For Solution | listed | FDA NDC | |
| United States | Cystadane | Recordati Rare Diseases | Powder, For Solution | listed | FDA NDC |
See every manufacturer of Betaine Hydrochloride worldwide →
Regulator price references for Betaine Hydrochloride
Published list or reimbursement prices for Betaine Hydrochloride presentations, in local currency, as at the date each registry last published. These are public reference prices, not Nexara Health quotes; strength and pack differ by row.
| Country | Product | Strength | Pack | Price | Type | Source | As of |
|---|---|---|---|---|---|---|---|
| Australia | Cystadane | Oral powder 180 g | 455.03 AUD | ex-manufacturer | PBS | 2026-09-08 | |
| Bahrain | Cystadane | 1000mg | 1 | 223.84 BHD | retail (max) | NHRA | 2026-09-01 |
| Greece | Kloref Ef.tab (1035+675)mg/Tab Βτχ30(Σε Πλαστ.φιαλ) | 5.12 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | ||
| Luxembourg | CYSTADANE PDRE ORALE 1 g 1*1 FL. 180 G + 1*3 CUILLERES MESURE | 1000mg+180000mg | 366.19 EUR | reimbursement | CNS liste positive | 2026-09-05 | |
| Saudi Arabia | Cystadane | 2,064.30 SAR | public | SFDA | 2026-09-01 | ||
| United Arab Emirates | Cystadane® 1g | 1000mg/1000mg | 1 HDPE Bottle with 180 g of Powder + 3 Measuring Spoons (1g, 150mg, 100mg) | 2,357.00 AED | public | EDE | 2026-08-31 |
Sourcing through Nexara Health
Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. This DIN is not currently marketed in Canada. The registrations above show which regulated markets hold an equivalent presentation that can be sourced for clinical comparator use or on a named-patient basis under Health Canada's Special Access Programme. Request a quote or read how named-patient and foreign-pack supply works in Canada.
Frequently asked questions
Is Homeopathic Medicine (S #414) - 30c Liq (DIN 02104962) marketed in Canada?
No. Health Canada lists DIN 02104962 as Cancelled Post Market as of 10 Sep 1996.
Who holds the Canadian licence for this product?
Total Health Centre is the company of record in the Health Canada Drug Product Database.
Is Betaine Hydrochloride registered outside Canada?
Yes — Nexara Health has matched 26 registrations in 14 other markets, including 1 in the same strength and dosage form (see the table above).
Where does this data come from?
Health Canada Drug Product Database (DPD), DIN 02104962, status date 1996-09-10; national medicine registries: CNS liste positive, EDE, EMA centrally authorised, EU national register, FDA NDC, HPRA, MoH deltio timwn, NHRA, NHS dm+d VMP, PBS, SFDA, SUKL DLP, TFDA, URPL RPL; price sources: CNS liste positive, EDE, MoH deltio timwn, NHRA, PBS, SFDA. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.
Source: Health Canada Drug Product Database (DPD), DIN 02104962, status date 1996-09-10; national medicine registries: CNS liste positive, EDE, EMA centrally authorised, EU national register, FDA NDC, HPRA, MoH deltio timwn, NHRA, NHS dm+d VMP, PBS, SFDA, SUKL DLP, TFDA, URPL RPL; price sources: CNS liste positive, EDE, MoH deltio timwn, NHRA, PBS, SFDA.
Health Canada Drug Product Database (DPD), DIN 02104962, status date 1996-09-10; national medicine registries: CNS liste positive, EDE, EMA centrally authorised, EU national register, FDA NDC, HPRA, MoH deltio timwn, NHRA, NHS dm+d VMP, PBS, SFDA, SUKL DLP, TFDA, URPL RPL; price sources: CNS liste positive, EDE, MoH deltio timwn, NHRA, PBS, SFDA. Last reviewed 2026-09-16. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.